Owens & Minor (NYSE:OMI - Get Free Report) is expected to announce its earnings results before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.54 per share and revenue of $2.73 billion for the quarter. Investors that wish to register for the company's conference call can do so using this link.
Owens & Minor Price Performance
Shares of OMI traded down $0.30 during mid-day trading on Friday, reaching $7.45. The stock had a trading volume of 1,560,012 shares, compared to its average volume of 1,055,074. The firm has a market cap of $574.08 million, a price-to-earnings ratio of -11.45, a PEG ratio of 0.25 and a beta of 0.48. Owens & Minor has a 12 month low of $7.41 and a 12 month high of $28.35. The business has a fifty day moving average of $12.80 and a 200 day moving average of $13.85. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on OMI shares. Robert W. Baird dropped their price target on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating for the company in a research report on Tuesday, February 4th. Barclays lowered their target price on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. UBS Group lowered their target price on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a report on Thursday. Finally, Citigroup lowered their target price on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $16.79.
View Our Latest Stock Analysis on Owens & Minor
Insider Activity at Owens & Minor
In related news, CFO Jonathan A. Leon sold 5,282 shares of the company's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now owns 130,822 shares of the company's stock, valued at $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.59% of the stock is owned by insiders.
About Owens & Minor
(
Get Free Report)
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Recommended Stories

Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.